A pooled analysis of CD4 response to zidovudine and zalcitabine treatment in patients with AIDS and AIDS-related complex

Clinical Pharmacology and Therapeutics

Volumn 61, Issue 1, 1997, Pages 70-82

  Gries, Jean Michel ^b   Troconiz, Iñaki F ^b   Verotta, Davide ^b   Jacobson, Mark ^b   Sheiner, Lewis B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; ZALCITABINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; DRUG POTENTIATION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AIDS-RELATED COMPLEX; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; DRUG THERAPY, COMBINATION; HUMANS; REGRESSION ANALYSIS; TIME FACTORS; ZALCITABINE; ZIDOVUDINE;

EID: 0031036466     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(97)90183-1     Document Type: Article

References (32)

1. DeVita VT, Schein PS. The use of drugs in combination for the treatment of cancer: rationale and results. N Engl J Med 1973;288:998-1006.
2. Klastersky J. Concept of empiric therapy with antibiotic combinations: indications and limits. Am J Med 1986;80(suppl 5C):2-12.
3. Fischl MA, Stanley K, Collier AC, Arduino JM, Stein DS, Feinberg JE, et al. Combination and monotherapy with zidovudine and zalcitabine in patients with advanced HIV disease. The NIAID AIDS Clinical Trials Group. Ann Intern Med 1995;122:24-32.
4. Meng TC, Fischl MA, Boota AM, Spector SA, Bennett D, Bassiakos Y, et al. Combination therapy with zidovudine and dideoxycytidine in patients with advanced human immunodeficiency virus infection. Ann Intern Med 1992;116:13-20.
5. Skowron G, Bozzette SA, Lim L. Alternating and intermittent regimens of zidovudine and dideoxycytidine in patients with AIDS or AIDS-related complex. Ann Intern Med 1993;118:321-30.
6. DeGruttola V, Wulfsohn M, Fischl MA. Modeling the relationship between survival and CD4 lymphocytes in patients with AIDS and AIDS-related complex. J Acquir Immune Defic Syndr Human Retrovirol 1993;6: 359-65.
7. Zeger SL, Diggle PJ. Semiparametric models for longitudinal data with applications to CD4 cell numbers in HIV seroconverts. Biometrics 1994;50:689-99.
8. Lawton WH, Sylvestre A, Maggio MS. Self modeling nonlinear regression. Technometrics 1972;14:513-32.
9. Bozette SA, Kanouse DE, Berry S, Duan N. Health status and function with zidovudine or zalcitabine as initial therapy for AIDS: a randomized controlled trial. JAMA 1995;273:295-301.
10. Fischl MA, Olson RM, Follansbee SE, Lalezari JP, Henry DH, Frame PT, et al. Zalcitabine compared with zidovudine in patients with advanced HIV-1 infection who received previous zidovudine therapy. Ann Intern Med 1993;118:762-69.
11. Choi S, Lagakos SW, Schooley RT, Volberding PA. CD4+ lymphocytes are an incomplete surrogate marker for clinical progression in persons with asymptomatic HIV infection taking zidovudine. Ann Intern Med 1993;118:674-80.
12. Hastie TJ, Tibshirani RJ. Generalized additive models. Monographs on statistics and applied probability 43. New York: Chapman and Hall, 1990.
13. Akaike H. A new look at the statistical model identification problem. IEEE Trans Automat Contr 1974; 19:716-23.
14. Cox DR, Hinckley DV. In: Cox DR, editor. Theoretical statistics. London: Chapman-Hall, 1974:chapter 9.
15. Bates DM, Watts DG. Nonlinear regression analysis and its applications. New York: John Wiley, 1988:205.
16. Waterhouse DM, Calzone KA, Mele C, Brenner DE. Adherence to oral tamoxifen: a comparison of patient self-report, pill counts, and microelectronic monitoring. J Clin Oncol 1993;11:1189-97.
17. Guerrero D, Rudd P, Bryant-Kosling C, Middleton BF. Antihypertensive medication-taking: investigation of a simple regimen. Am J Hypertens 1993;6:586-92.
18. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
19. Goodman SN. Meta-analysis and evidence. Control Clin Trials 1989;10:188-204.
20. Kojima E, Shirasaka T, Anderson BD. Human immunodeficiency virus type 1 viremia changes and development of drug-related mutations in patients with symptomatic HIV-1 infection receiving alternating or simultaneous zidovudine and didanosine therapy. J Infect Dis 1995;171:1152-8.
21. Fischl MA, Richman DD, Grieco MH, Gottlieb MS, Volberding PA, Laskin OL, et al. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: a double-blind placebo-controlled trial. N Engl J Med 1987;317:185-91.
22. Lange N, Laird NM. The effect of covariance structure on variance estimation in balanced growth-curve models with random parameters. J Am Stat Assoc 1989;84: 241-7.
23. Seligmann M, Pinching A, Rosen F, Fahey JL, Khaitov RM, Klatzman D, et al. Immunology of human immunodeficiency syndrome infection and the acquired immunodeficiency syndrome: an update. Ann Intern Med 1987;107:234-42.
24. DeBoor C. A practical guide to splines. New York: Springer-Verlag, 1978.
25. Verotta D. Longitudinal splines: technical report 36. San Francisco: Department of Biostatistics, UCSF, 1993.
26. Verotta D. New approaches to self-modeling nonlinear regression. In: D'Argenio DZ, editor. Advanced methods of pharmacokinetic and pharmacodynamic system analysis II. New York: Plenum, 1995.
27. Fattinger KE, Verotta D. A nonparametric subject-specific population methods for deconvolution; I: description, internal validation and real data examples. J Pharmacokinet Biopharm 1996;23.
28. Fattinger KE, Verotta D. A nonparametric subject-specific population methods for deconvolution; II: external validation. J Pharmacokinet Biopharm 1996;23.
29. Beal SL, Boeckmann AJ, Sheiner LB. NONMEM users guides. San Francisco: NONMEM Project Group, UCSF, 1992.
30. Guardabasso V, Rodbard D, Munson PJ. A model-free approach to estimation of relative potency in dose-response curve analysis. Am J Physiol 1987; 252(Endocrinol Metab 15):E357-64.
31. Verotta D, Sheiner LB. Comparing responses when each response is a curve. Am J Physiol 1992;263: R206-14.
32. Lindstrom MJ. Self-modelling with random shift and scale parameters and a free-knot spline shape function. Stat Med 1995;14:2009-21.